Brean Murray Carret initiates coverage on Inovio Pharmaceuticals (AMEX: INO) with a Buy rating and $2.00 price target.
This article: 91 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE